Compounds > theophylline
Page last updated: 2024-10-22

theophylline and Hyperlipoproteinemia Type II

theophylline has been researched along with Hyperlipoproteinemia Type II in 2 studies

Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haacke, H2
Parwaresch, MR2
Mäder, C2
Fears, R1
Ferres, H1

Trials

1 trial available for theophylline and Hyperlipoproteinemia Type II

ArticleYear
Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin.
    Atherosclerosis, 1988, Volume: 69, Issue:2-3

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Cli

1988

Other Studies

1 other study available for theophylline and Hyperlipoproteinemia Type II

ArticleYear
Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
    Atherosclerosis, 1980, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Aged; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteine

1980